Responses
Evidence based practice
Research
Effectiveness, safety and costs of orphan drugs: an evidence-based review
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 15 March 2016
- Published on: 15 March 2016Publication in BMJ Open: Onakpoya IJ, et al. BMJ Open 2015;5:e007199 - Inaccurate information and CommentShow More
We read this article with great interest and would like to congratulate the authors on conducting an evidence based study on effectiveness, safety and cost of orphan medicinal products. Laboratoires CTRS is a pharmaceutical company specialising in orphan medicinal products.
We would like to correct certain inaccurate information within this article concerning Laboratoires CTRS' medicinal product Orphacol (choli...
Conflict of Interest:
None declared.